GL1X · GenesisL1 explorer

Ligand · HMY

HMY · (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione

HMY, (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione (C19 H22 O8, 378.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB…

Component
HMY
Formula
C19 H22 O8
Class
ligand
Structures
2
PDB entries
1

Binding sites

HMY in 2 structures; the first of them:

  • 3C9W · Crystal Structure of ERK-2 with hypothemycin covalently bound · HMY A1 · binds ILE29, VAL37, ALA50, LYS52, GLN103, ASP104, LEU105, MET106 and 9 more
  • 3C9W · Crystal structure of ERK-2 with hypothemycin covalently bound · HMY A1 · binds ILE29, VAL37, ALA50, LYS52, GLN103, ASP104, LEU105, MET106 and 9 more

Residues it binds most

ASP 4, LEU 4, LYS 4, ILE 4, ALA 4, ASN 4, CYS 4, GLN 4, GLU 4, MET 4 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.